US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist

47.100
+0.250+0.53%

Trading Nov 15 13:25 ET

4.02BMarket Cap-16881P/E (TTM)

CRISPR Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

84,762.39%370M

3,333,233.33%200M

44,203.80%70M

56,079.78%100M

-99.95%436K

-99.95%6K

Operating revenue

--0

84,762.39%370M

3,333,233.33%200M

--0

44,203.80%70M

56,079.78%100M

-99.95%436K

-99.95%6K

Cost of revenue

-52.38%11.15M

16.79%52.13M

11.31%46.97M

18.14%130.25M

193.13%20M

-39.73%23.42M

31.58%44.64M

37.68%42.19M

8.97%110.25M

-78.56%6.82M

Gross profit

52.38%-11.15M

-305.53%-52.13M

-181.24%-46.97M

318.32%239.75M

2,740.46%180M

39.58%-23.42M

175.12%25.36M

289.73%57.81M

-113.53%-109.81M

65.00%-6.82M

Operating expense

-9.19%98.98M

-17.79%99.13M

-23.45%93.62M

-17.94%462.29M

-11.47%110.42M

-24.11%108.99M

-19.34%120.59M

-15.95%122.3M

28.51%563.35M

-1.19%124.72M

Selling and administrative expenses

-4.77%17.42M

2.36%19.48M

-19.71%17.95M

-25.67%76.16M

-22.16%16.48M

-32.26%18.29M

-27.56%19.03M

-20.20%22.36M

2.78%102.46M

-10.60%21.17M

-General and administrative expense

-4.77%17.42M

2.36%19.48M

-19.71%17.95M

-25.67%76.16M

-22.16%16.48M

-32.26%18.29M

-27.56%19.03M

-20.20%22.36M

2.78%102.46M

-10.60%21.17M

Research and development costs

-9.41%82.16M

-21.06%80.17M

-23.78%76.17M

-16.10%387.33M

-8.12%95.14M

-22.23%90.7M

-17.58%101.56M

-15.48%99.94M

35.55%461.65M

0.45%103.56M

Other operating expenses

---602K

---517K

---504K

-58.27%-1.21M

----

59.51%-762K

--0

Operating profit

16.83%-110.13M

-58.85%-151.26M

-118.01%-140.59M

66.94%-222.54M

152.90%69.58M

27.40%-132.41M

48.04%-95.22M

63.35%-64.49M

-280.22%-673.16M

9.72%-131.54M

Net non-operating interest income expense

Other net income (expense)

21.25%25.06M

42.01%26.14M

94.00%24.72M

216.91%71.82M

74.04%20M

184.57%20.67M

419.36%18.41M

3,410.19%12.74M

277.49%22.66M

422.99%11.49M

Other non- operating income (expenses)

21.25%25.06M

42.01%26.14M

94.00%24.72M

216.91%71.82M

74.04%20M

184.57%20.67M

419.36%18.41M

3,410.19%12.74M

277.49%22.66M

422.99%11.49M

Income before tax

23.87%-85.07M

-62.88%-125.12M

-123.92%-115.87M

76.83%-150.72M

174.62%89.58M

36.19%-111.74M

57.26%-76.82M

70.53%-51.75M

-271.40%-650.5M

16.34%-120.05M

Income tax

112.62%876K

39.44%1.29M

-45.15%724K

988.62%2.89M

102.46%233K

171.65%412K

-84.91%923K

-63.41%1.32M

-117.38%-325K

-320.59%-9.48M

Net income

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

76.37%-153.61M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.07M

-272.16%-650.18M

21.72%-110.58M

Net income continuous Operations

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

76.37%-153.61M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.07M

-272.16%-650.18M

21.72%-110.58M

Minority interest income

Net income attributable to the parent company

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

76.37%-153.61M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.07M

-272.16%-650.18M

21.72%-110.58M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

76.37%-153.61M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.07M

-272.16%-650.18M

21.72%-110.58M

Basic earnings per share

28.37%-1.01

-52.04%-1.49

-113.43%-1.43

76.79%-1.94

180.14%1.13

37.05%-1.41

59.17%-0.98

71.12%-0.67

-268.21%-8.36

23.37%-1.41

Diluted earnings per share

28.37%-1.01

-52.04%-1.49

-113.43%-1.43

76.79%-1.94

180.14%1.13

37.05%-1.41

59.17%-0.98

71.12%-0.67

-277.87%-8.36

23.37%-1.41

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	84,762.39%370M	3,333,233.33%200M	0	44,203.80%70M	56,079.78%100M	-99.95%436K	-99.95%6K
Operating revenue	--0	--0	--0	84,762.39%370M	3,333,233.33%200M	--0	44,203.80%70M	56,079.78%100M	-99.95%436K	-99.95%6K
Cost of revenue	-52.38%11.15M	16.79%52.13M	11.31%46.97M	18.14%130.25M	193.13%20M	-39.73%23.42M	31.58%44.64M	37.68%42.19M	8.97%110.25M	-78.56%6.82M
Gross profit	52.38%-11.15M	-305.53%-52.13M	-181.24%-46.97M	318.32%239.75M	2,740.46%180M	39.58%-23.42M	175.12%25.36M	289.73%57.81M	-113.53%-109.81M	65.00%-6.82M
Operating expense	-9.19%98.98M	-17.79%99.13M	-23.45%93.62M	-17.94%462.29M	-11.47%110.42M	-24.11%108.99M	-19.34%120.59M	-15.95%122.3M	28.51%563.35M	-1.19%124.72M
Selling and administrative expenses	-4.77%17.42M	2.36%19.48M	-19.71%17.95M	-25.67%76.16M	-22.16%16.48M	-32.26%18.29M	-27.56%19.03M	-20.20%22.36M	2.78%102.46M	-10.60%21.17M
-General and administrative expense	-4.77%17.42M	2.36%19.48M	-19.71%17.95M	-25.67%76.16M	-22.16%16.48M	-32.26%18.29M	-27.56%19.03M	-20.20%22.36M	2.78%102.46M	-10.60%21.17M
Research and development costs	-9.41%82.16M	-21.06%80.17M	-23.78%76.17M	-16.10%387.33M	-8.12%95.14M	-22.23%90.7M	-17.58%101.56M	-15.48%99.94M	35.55%461.65M	0.45%103.56M
Other operating expenses	---602K	---517K	---504K	-58.27%-1.21M	----	----	----	----	59.51%-762K	--0
Operating profit	16.83%-110.13M	-58.85%-151.26M	-118.01%-140.59M	66.94%-222.54M	152.90%69.58M	27.40%-132.41M	48.04%-95.22M	63.35%-64.49M	-280.22%-673.16M	9.72%-131.54M
Net non-operating interest income expense
Other net income (expense)	21.25%25.06M	42.01%26.14M	94.00%24.72M	216.91%71.82M	74.04%20M	184.57%20.67M	419.36%18.41M	3,410.19%12.74M	277.49%22.66M	422.99%11.49M
Other non- operating income (expenses)	21.25%25.06M	42.01%26.14M	94.00%24.72M	216.91%71.82M	74.04%20M	184.57%20.67M	419.36%18.41M	3,410.19%12.74M	277.49%22.66M	422.99%11.49M
Income before tax	23.87%-85.07M	-62.88%-125.12M	-123.92%-115.87M	76.83%-150.72M	174.62%89.58M	36.19%-111.74M	57.26%-76.82M	70.53%-51.75M	-271.40%-650.5M	16.34%-120.05M
Income tax	112.62%876K	39.44%1.29M	-45.15%724K	988.62%2.89M	102.46%233K	171.65%412K	-84.91%923K	-63.41%1.32M	-117.38%-325K	-320.59%-9.48M
Net income	23.37%-85.94M	-62.60%-126.41M	-119.71%-116.59M	76.37%-153.61M	180.80%89.35M	35.75%-112.15M	58.17%-77.74M	70.39%-53.07M	-272.16%-650.18M	21.72%-110.58M
Net income continuous Operations	23.37%-85.94M	-62.60%-126.41M	-119.71%-116.59M	76.37%-153.61M	180.80%89.35M	35.75%-112.15M	58.17%-77.74M	70.39%-53.07M	-272.16%-650.18M	21.72%-110.58M
Minority interest income
Net income attributable to the parent company	23.37%-85.94M	-62.60%-126.41M	-119.71%-116.59M	76.37%-153.61M	180.80%89.35M	35.75%-112.15M	58.17%-77.74M	70.39%-53.07M	-272.16%-650.18M	21.72%-110.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	23.37%-85.94M	-62.60%-126.41M	-119.71%-116.59M	76.37%-153.61M	180.80%89.35M	35.75%-112.15M	58.17%-77.74M	70.39%-53.07M	-272.16%-650.18M	21.72%-110.58M
Basic earnings per share	28.37%-1.01	-52.04%-1.49	-113.43%-1.43	76.79%-1.94	180.14%1.13	37.05%-1.41	59.17%-0.98	71.12%-0.67	-268.21%-8.36	23.37%-1.41
Diluted earnings per share	28.37%-1.01	-52.04%-1.49	-113.43%-1.43	76.79%-1.94	180.14%1.13	37.05%-1.41	59.17%-0.98	71.12%-0.67	-277.87%-8.36	23.37%-1.41
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data